Please login or sign up to post and edit reviews.
Why WeightWatchers Wants in on Drugs Like Ozempic - Publication Date |
- Mar 14, 2023
- Episode Duration |
- 00:18:08
WeightWatchers is buying digital health company Sequence to capitalize on the hot market for diabetes and weight loss drugs including Ozempic and Wegovy. WSJ's Andrea Petersen explains what this could mean for the wellness industry.
Further Reading:
-WeightWatchers Moves Into the Ozempic Market With Telehealth Deal
-How a Diabetes Drug Became the Talk of Hollywood, Tech and the Hamptons
-Health Startups Offer Diabetes Drugs Like Ozempic for Weight Loss With Little Oversight
Learn more about your ad choices. Visit
megaphone.fm/adchoicesThis episode could use a review!
This episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review